1naresh2naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) [2f71b656-794e-4c43-9ccf-7205b8bed83a] => Array ( [runtime-id] => 2f71b656-794e-4c43-9ccf-7205b8bed83a [type] => toll-free-key [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [8e3cdb8c-2a6c-4ff3-9f50-f6bc3a59b1e8] => Array ( [runtime-id] => 8e3cdb8c-2a6c-4ff3-9f50-f6bc3a59b1e8 [type] => toll-free-key ) ) [credentials] => Array ( [method] => toll-free-key [value] => tf_ipsecsha;323f5b6a768394bafcb769ca48ca09135640676d ) ) ) 1naresh2nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) [2f71b656-794e-4c43-9ccf-7205b8bed83a] => Array ( [runtime-id] => 2f71b656-794e-4c43-9ccf-7205b8bed83a [type] => toll-free-key [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [8e3cdb8c-2a6c-4ff3-9f50-f6bc3a59b1e8] => Array ( [runtime-id] => 8e3cdb8c-2a6c-4ff3-9f50-f6bc3a59b1e8 [type] => toll-free-key ) ) [credentials] => Array ( [method] => toll-free-key [value] => tf_ipsecsha;323f5b6a768394bafcb769ca48ca09135640676d ) ) )Table 1:Metabolite peak-area ratios for Lac/Cr, Lac/NAA, Lac/Cho, NAA/Cr, NAA/Cho, and Cho/Cr
Metabolite Ratio Control Group (n = 10) Neonatal Encephalopathy Group (n = 17) P Values Normal/Mild Outcome (n = 10) Severe/Fatal Outcome (n = 7) Control Versus Normal/Mild Outcome Control Versus Severe/Fatal Outcome Normal/Mild Outcome Versus Severe/Fatal Outcome Lac/Cr 0.38 (0.10) 0.41 (0.13) 0.70 (0.45β2.65) .61 .04* .06 Lac/NAA 0.24 (0.06) 0.29 (0.09) 0.54 (0.35β2.66) .11 .02* .03* Lac/Cho 0.15 (0.03) 0.19 (0.05) 0.32 (0.22β1.26) .06 .02* .04* NAA/Cr 1.59 (0.19) 1.41 (0.28) 1.16 (0.14) .09 <.001* .04* NAA/Cho 0.66 (0.08) 0.67 (0.09) 0.56 (0.11) .73 .04* .04* Cho/Cr 2.47 (0.57) 2.10 (0.31) 2.12 (0.36) .09 .17 .91
Note:βLac indicates lactate; NAA, N-acetylaspartate; Cho, choline; Cr, creatine.
* Denotes statistically significant differences between the groups. Values are mean (SD) and median (interquartile range) as appropriate.